Erin E Hahn1, Patricia A Ganz. 1. Division of Cancer Prevention & Control Research and UCLA-LIVESTRONG Survivorship Center of Excellence, Jonsson Comprehensive Cancer Center at UCLA; UCLA Schools of Medicine & Public Health, Los Angeles, CA.
Abstract
PURPOSE: THIS QUALITATIVE STUDY EXAMINED CANCER SURVIVORSHIP PROGRAMS AT FOUR HEALTH CARE ORGANIZATIONS IN LOS ANGELES COUNTY, CA: an academic medical center, a community hospital, a primary-care medical group, and a county hospital. The purpose was to describe the successful implementation of four distinctly different models of care, focusing on the creative development and use of the Institute of Medicine-recommended survivorship care plan (SCP) document in each setting. METHODS: In-depth semistructured interviews were done with survivorship teams to characterize each program and the development and use of the SCP at each institution. RESULTS: Each survivorship program has developed and implemented unique types of SCP documents. Specifically, a comprehensive SCP at the academic center, completed by the clinical team, which covers many facets of cancer survivorship; a patient-directed SCP at the community hospital, completed by the survivor with assistance of an oncology nurse and focused on treatment history and appropriate surveillance; an adapted ASCO SCP template at the primary-care medical group, completed via a partnership with contracted oncologists and focused on the treatment history, surveillance, and shared care between oncology and primary care; an adapted ASCO SCP template at the county hospital, completed by the survivorship nurse practitioner and focused on patient education, post-treatment care, and institutional care coordination. CONCLUSION: The SCP document is a flexible tool that can be successfully adapted for use in extremely varied settings, from primary care to hospitals, to inform and educate patients and providers alike.
PURPOSE: THIS QUALITATIVE STUDY EXAMINED CANCER SURVIVORSHIP PROGRAMS AT FOUR HEALTH CARE ORGANIZATIONS IN LOS ANGELES COUNTY, CA: an academic medical center, a community hospital, a primary-care medical group, and a county hospital. The purpose was to describe the successful implementation of four distinctly different models of care, focusing on the creative development and use of the Institute of Medicine-recommended survivorship care plan (SCP) document in each setting. METHODS: In-depth semistructured interviews were done with survivorship teams to characterize each program and the development and use of the SCP at each institution. RESULTS: Each survivorship program has developed and implemented unique types of SCP documents. Specifically, a comprehensive SCP at the academic center, completed by the clinical team, which covers many facets of cancer survivorship; a patient-directed SCP at the community hospital, completed by the survivor with assistance of an oncology nurse and focused on treatment history and appropriate surveillance; an adapted ASCO SCP template at the primary-care medical group, completed via a partnership with contracted oncologists and focused on the treatment history, surveillance, and shared care between oncology and primary care; an adapted ASCO SCP template at the county hospital, completed by the survivorship nurse practitioner and focused on patient education, post-treatment care, and institutional care coordination. CONCLUSION: The SCP document is a flexible tool that can be successfully adapted for use in extremely varied settings, from primary care to hospitals, to inform and educate patients and providers alike.
Authors: Kim M Gans; Patricia M Risica; Judith Wylie-Rosett; Elizabeth M Ross; Leslie O Strolla; Jerome McMurray; Charles B Eaton Journal: J Nutr Educ Behav Date: 2006 Sep-Oct Impact factor: 3.045
Authors: K Robin Yabroff; William F Lawrence; Steven Clauser; William W Davis; Martin L Brown Journal: J Natl Cancer Inst Date: 2004-09-01 Impact factor: 13.506
Authors: Kim M Gans; Elizabeth Ross; Claudia W Barner; Judith Wylie-Rosett; Jerome McMurray; Charles Eaton Journal: J Nutr Date: 2003-02 Impact factor: 4.798
Authors: Patricia A Ganz; Gail A Greendale; Laura Petersen; Barbara Kahn; Julienne E Bower Journal: J Clin Oncol Date: 2003-11-15 Impact factor: 44.544
Authors: Mylène Bassal; Ann C Mertens; Leslie Taylor; Joseph P Neglia; Brian S Greffe; Sue Hammond; Cécile M Ronckers; Debra L Friedman; Marilyn Stovall; Yutaka Y Yasui; Leslie L Robison; Anna T Meadows; Nina S Kadan-Lottick Journal: J Clin Oncol Date: 2006-01-20 Impact factor: 50.717
Authors: Wassim Chemaitilly; Ann C Mertens; Pauline Mitby; John Whitton; Marilyn Stovall; Yutaka Yasui; Leslie L Robison; Charles A Sklar Journal: J Clin Endocrinol Metab Date: 2006-02-21 Impact factor: 6.134
Authors: Carol A Rosenberg; Carol Flanagan; Bruce Brockstein; Jennifer C Obel; Leon H Dragon; Douglas E Merkel; Elaine L Wade; Teresa M Law; Janardan D Khandekar; Thomas A Hensing Journal: J Cancer Surviv Date: 2015-07-16 Impact factor: 4.442
Authors: Gisela Michel; Renée L Mulder; Helena J H van der Pal; Roderick Skinner; Edit Bárdi; Morven C Brown; Janine Vetsch; Eva Frey; Rachael Windsor; Leontien C M Kremer; Gill Levitt Journal: J Cancer Surviv Date: 2019-08-08 Impact factor: 4.442
Authors: Talya Salz; Mary S McCabe; Erin E Onstad; Shrujal S Baxi; Richard L Deming; Regina A Franco; Lyn A Glenn; Gregory R Harper; Alcee J Jumonville; Roxanne M Payne; Elissa A Peters; Andrew L Salner; John M Schallenkamp; Sheron R Williams; Kevin Yiee; Kevin C Oeffinger Journal: Cancer Date: 2013-12-10 Impact factor: 6.860